Literature DB >> 6474387

Comparison of cumulative and non-cumulative techniques to measure dose-response curves for beta agonists in patients with asthma.

J Britton, A Tattersfield.   

Abstract

It has been suggested that the use of a cumulative technique to obtain bronchodilator dose-response curves will cause a greater response than a non-cumulative technique, because sequential doses of drug will penetrate further into the lung. To test this hypothesis we have compared cumulative and non-cumulative dose-response curves for inhaled isoprenaline in 10 subjects with stable asthma, measuring FEV1, forced vital capacity (FVC), and peak expiratory flow rate (PEFR). With both techniques there was an increased response with increasing doses of isoprenaline for all the dose-response curves except for the non-cumulative PEFR response, which reached a plateau with the 20 micrograms dose. The area under the dose-response curve for FEV1 was significantly greater after cumulative administration of isoprenaline than with the non-cumulative technique. The increase in FVC and PEFR tended to be greater with the cumulative technique but the differences were not significant. This study confirms that the airway response to an inhaled beta agonist may be greater when a cumulative inhalation technique is used.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6474387      PMCID: PMC1020512          DOI: 10.1136/thx.39.8.597

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  6 in total

1.  A comparison of the actions of different bronchodilators in asthma.

Authors:  B J Freedman; P Meisner; G B Hill
Journal:  Thorax       Date:  1968-11       Impact factor: 9.139

Review 2.  Airways penetration of inhaled radioaerosol: an index to small airways function?

Authors:  J E Agnew; D Pavia; S W Clarke
Journal:  Eur J Respir Dis       Date:  1981-08

3.  Clinical assessment of bronchodilator drugs delivered by aerosol.

Authors:  G M Shenfield; J W Paterson
Journal:  Thorax       Date:  1973-03       Impact factor: 9.139

4.  Time factor in the measurement of response to bronchodilators.

Authors:  G J Mushin
Journal:  Thorax       Date:  1967-11       Impact factor: 9.139

5.  Dose response of patients with asthma to inhaled isoproterenol.

Authors:  M H Williams; C Kane
Journal:  Am Rev Respir Dis       Date:  1975-03

6.  Influence of age on response to ipratropium and salbutamol in asthma.

Authors:  M I Ullah; G B Newman; K B Saunders
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

  6 in total
  9 in total

Review 1.  Discriminating measures of bronchodilator drug efficacy and potency.

Authors:  H Buck; M Parry-Billings
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

Review 2.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

3.  Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.

Authors:  E T Smyth; I D Pavord; C S Wong; A F Wisniewski; J Williams; A E Tattersfield
Journal:  BMJ       Date:  1993-02-27

Review 4.  Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society.

Authors:  R C Beveridge; A F Grunfeld; R V Hodder; P R Verbeek
Journal:  CMAJ       Date:  1996-07-01       Impact factor: 8.262

5.  Randomised pragmatic comparison of UK and US treatment of acute asthma presenting to hospital.

Authors:  N J Innes; J A Stocking; T J Daynes; B D W Harrison
Journal:  Thorax       Date:  2002-12       Impact factor: 9.139

6.  Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.

Authors:  D Donnell; L I Harrison; S Ward; N M Klinger; B P Ekholm; K M Cooper; I Porietis; J McEwen
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

7.  Dose response to inhaled salbutamol in chronic obstructive airways disease.

Authors:  C Teale; J F Morrison; R L Page; S B Pearson
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

8.  Exemplary Practices in Cardiovascular Care: Results on Clinical Quality Measures from the EvidenceNOW Southwest Cooperative.

Authors:  Douglas H Fernald; Rebecca Mullen; Tristen Hall; Andrew Bienstock; Stephanie Kirchner; Kyle Knierim; Dionisia de la Cerda; Danelle Callan; Robert L Rhyne; L Miriam Dickinson; W Perry Dickinson
Journal:  J Gen Intern Med       Date:  2020-08-17       Impact factor: 5.128

9.  Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.

Authors:  J B Wempe; D S Postma; N Breederveld; E Kort; T W van der Mark; G H Koëter
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.